Tag: ERBB2-low

Choosing Wisely campaign releases recommendations in newborn medicine

ERBB2-low tumours are not a distinct biologic or prognostic subgroup from ERBB2-0 tumour breast cancer.

byKassandra McFarlaneand1 others

July 11, 2022

1. No significant difference in pCR, DFS, or OS was found for subgroup analysis of ERBB2-0 vs. ERBB2-low tumours 2. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

No Result

View All Result

Tag: ERBB2-low

ERBB2-low tumours are not a distinct biologic or prognostic subgroup from ERBB2-0 tumour breast cancer.

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits